Traci C Green

Professor and Director of the Opioid Policy Research Collaborative

Traci C Green's photo

Contact

Email: tracigreen@brandeis.edu
Office: Heller-Brown Building 256
Phone: 781-736-2609
Brandeis Directory

Expertise

epidemiology, drug use, opioid use disorder, drug-related injury

Traci C Green

Professor and Director of the Opioid Policy Research Collaborative

Profile

Dr. Green is an epidemiologist whose research focuses on drug use, opioid use disorder, and drug-related injury. She earned a Master of Science in Epidemiology and Biostatistics from McGill University and a PhD in Epidemiology from Yale University. She helped design the ASI-MV®, a real-time illicit and prescription drug abuse surveillance system developed by Inflexxion, Inc. Prior to joining the Heller School at Brandeis, she served as Deputy Director of the Boston Medical Center Injury Prevention Center, Associate Professor of Emergency Medicine and Community Health Sciences at the Boston University Schools of Medicine and Public Health. She is an Adjunct Associate Professor at the Warren Alpert School of Medicine at Brown University where she co-directs the Center of Biomedical Research Excellence (COBRE) on Opioids and Overdose at Rhode Island Hospital. Dr. Green helped co-found www.prescribetoprevent.org for prescribers and pharmacists and its companion site www.prevent-protect.org for families, patients, and community organizations. She serves as an advisor to the Rhode Island Governor on addiction and overdose, and consults for the Center for Disease Control and Prevention and the High Intensity Drug Trafficking Areas on public health and public safety opportunities. She served on the Board of Scientific Counselors for the CDC’s National Center for Injury Prevention and Control and two recent National Academy of Sciences, Engineering, and Medicine’s Committees pertaining to opioid pain management, regulatory strategies to address opioids, and medications for opioid use disorder. Her research is supported by the CDC, the National Institute on Drug Abuse, the Agency for Healthcare Research and Quality, the Patient Centered Outcomes Research Institute, the Bloomberg American Health Initiative, and the Department of Justice.

Scholarship

  • M Irvine, D Coombs, J Skarha, B del Pozo, J Rich, F Taxman, TC Green. "Modeling COVID-19 and impacts on U.S. Immigration and Customs Enforcement (ICE) detention facilities, 2020." Journal of Urban Health 2020. (2020). (forthcoming)
  • S Wakeman, TC Green, JD Rich. "An overdose surge will compound the COVID-19 pandemic if urgent action is not taken." Nature Medicine 2020. (2020).
  • T Green, J Bratberg, & D.S. Finnell. "Opioid use disorder and the COVID 19 pandemic: A call to sustain regulatory easements and further expand access to treatment." Substance Abuse 2020. (2020).
  • TC Green, A Soipe, B Baloy, D Burstein, Z Xuan, A Tapper, AY Walley, P Case, J Bratberg & J Baird. "Pharmacy on-site overdose protocols and prevention of overdose." Substance Abuse 2020. (2020).
  • TC Green, C Davis, Z Xuan, AY Walley, J Bratberg.. "Laws Mandating Coprescription of Naloxone and Their Impact on Naloxone Prescription in Five US States, 2014–2018.." American Journal of Public Health 110. (2020): 881-887.